Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects

Area of Science:

• Cardiovascular Research
• Immunology
• Molecular Biology

Background:

• Chemokines contribute to atherosclerosis by recruiting leukocytes.
• Stromal cell-derived factor (SDF)-1 exhibits anti-inflammatory properties.
• The role of SDF-1 in coronary artery disease requires further investigation.

Purpose of the Study:

• To investigate the potential beneficial role of SDF-1alpha in coronary artery disease.
• To examine SDF-1alpha levels and its receptor CXCR-4 expression in angina patients.
• To assess the in vitro effects of SDF-1alpha on inflammatory mediators in peripheral blood mononuclear cells (PBMCs).

Main Methods:

• Plasma SDF-1alpha levels were measured in patients with stable/unstable angina and healthy controls.
• Flow cytometry and RNase protection assays were used to analyze CXCR-4 expression in PBMCs.
• In vitro experiments treated PBMCs with SDF-1alpha to evaluate changes in inflammatory marker gene and protein expression.

Main Results:

• SDF-1alpha plasma levels were significantly lower in angina patients, especially those with unstable disease.
• Decreased surface and increased gene expression of CXCR-4 were observed in PBMCs from angina patients.
• In vitro, SDF-1alpha reduced pro-inflammatory mediators (MCP-1, IL-8, MMP-9) and tissue factor, while increasing TIMP-1 in PBMCs from unstable angina patients.

Conclusions:

• SDF-1alpha may exert anti-inflammatory and matrix-stabilizing effects in unstable angina, potentially through high concentrations.
• These findings suggest SDF-1alpha's role in promoting plaque stabilization.
• Therapeutic strategies enhancing SDF-1alpha activity could benefit patients with acute coronary syndromes.